Author:
Kim Jong-Heun,Fang Chun-Kai
Publisher
Springer Berlin Heidelberg
Reference31 articles.
1. American Psychiatric Association: Diagnostic and Statistical Manual forMental Disorders – Fith edition (DSM5). American Psychiatric Publishing, Washington, DC. 2013.
2. Baba O, Yamagata K, Tomidokoro Y, Tamaoka A, Itoh H, Yanagawa T, Onizawa K, Bukawa H. Neuroleptic malignant syndrome in a patient with tongue cancer: a report of a rare case. Case Rep Dent. 2013;2013:542130.
3. Brell JM. Prolonged QTc interval in cancer therapeutic drug development: defining arrhythmic risk in malignancy. Prog Cardiovasc Dis. 2010;53(2):164–72.
4. Burgess DJ. Anticancer drugs: antipsychotic to anticancer agent? Nat Rev Drug Discov. 2012;11(7):516.
5. Chochinov HM, Martens PJ, Prior HJ, Kredentser MS. Comparative health care use patterns of people with schizophrenia near the end of life: a population-based study in Manitoba, Canada. Schizophr Res. 2012;141:241–16.